Long-term follow-up of 18 patients with myelodysplastic syndromes responding to recombinant erythropoietin treatment

International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

Peter L. Greenberg, Christopher Cox, Michelle M. LeBeau et al. · Blood · 1997 · 4.5K citations · Full text

Medicine, Hematology, Internal Medicine +13

Erythroid response to treatment with G‐CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model

Eva Hellström‐Lindberg, Robert S. Negrin, Richard S. Stein et al. · British Journal of Haematology · 1997 · 314 citations

Medicine, Hematology, Pharmacotherapy +14

Treatment of Anemia in Myelodysplastic Syndromes With Granulocyte Colony-Stimulating Factor Plus Erythropoietin: Results From a Randomized Phase II Study and Long-Term Follow-Up of 71 Patients

Eva Hellström-Lindberg, Tomas Ahlgren, Yves Béguin et al. · Blood · 1998 · 306 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy

RS Negrin, R S Stein, Kathleen Doherty et al. · Blood · 1996 · 209 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes [see comments]

R S Stein, RI Abels, SB Krantz · Blood · 1991 · 143 citations · Full text

Medicine, Hematology, Pharmacology +8